Results 141 to 150 of about 1,044,480 (214)

Carbon Quantum Dots: From Mechanisms to Biomedical Applications

MedComm, Volume 7, Issue 10, October 2026.
Carbon quantum dots (CQDs) are promising carbon‐based nanomaterials with broad biomedical applications, including bioimaging, drug delivery, biosensing, and tissue regeneration. This Review summarizes the biological mechanisms of CQDs in tissue regeneration, focusing on their regulation of cellular functions, immune responses, and redox balance.
Bingxin Fan, Nianqiang Jin, Nuo Jin, Jiayu Shen, Xinliang Duan, Sichen Han, Yao Yuan, Zilin Wang   +7 more
wiley   +1 more source

Iron, Tuberculosis, and Particle-Related Exposures Including Smoking. [PDF]

Pathogens
Ghio AJ, Pennington ER, Pulczinski JC, Hilborn ED, Tilley SL.   +4 more
europepmc   +1 more source

Receptor‐Targeted Niosomal Nanocarriers: Advances, Challenges, and Opportunities in Natural Compound Delivery for Cancer Therapy

Nano Select, Volume 7, Issue 10, October 2026.
Surface‐modified niosomes are introduced as multifunctional nanoparticles for precision tumor treatment that combine hydrophilic and lipophilic drug encapsulation with ligand‐based targeting via antibodies, peptides, transferrin, and folic acid. This modification leads to increased tumor selectivity, facilitates cell entry, and enables enhanced ...
Narges Sahraei, Aryan M. Faraj, Faezeh Molaei, Abolfazl Barzegar   +3 more
wiley   +1 more source

Cordycepin Alleviates Non Alcoholic Fatty Liver Disease Progression by Stabilizing GCH1 to Inhibit Ferroptosis

Phytotherapy Research, Volume 40, Issue 10, Page 5886-5900, October 2026.
COR stabilizes GCH1 and inhibits ferroptosis. ABSTRACT To investigate the effects and targets of cordycepin (COR) in alleviating non‐alcoholic fatty liver disease (NAFLD). High‐fat diet was used to induce NAFLD in mice, and after COR gavage administration, changes in liver function, glucose and lipid metabolism, and ferroptosis‐related signaling were ...
Chenyang Han, Jian Sheng, Hongyan Pei, Wenyan Li, Shasha Wu, Yi Yang, Chenxi Cao, Zhiling Tang   +7 more
wiley   +1 more source

Comprehensive Health Predictors of Injury, Illness, and Separation From Service After Enrollment in Special Forces Assessment and Selection: A Two‐Year Longitudinal Study

Stress and Health, Volume 42, Issue 5, October 2026.
ABSTRACT Individuals in physically and cognitively demanding professions face increased risk of injury, illness, and attrition due to repeated exposure to physical and psychological stressors. Identifying modifiable factors associated with these outcomes can guide risk mitigation strategies.
Meaghan E. Beckner, Emily K. Farina, Lauren A. Thompson, Joseph J. Knapik, Stefan M. Pasiakos, James P. McClung, Harris R. Lieberman   +6 more
wiley   +1 more source

Ferritin and Soluble Transferrin Receptor Beyond Inflammation: Independent Associations with Fasting Glucose and Metabolic Syndrome in a Central Asian Cohort. [PDF]

Diagnostics (Basel)
Kaldarkhan D, Sadykova K, Oshibayeva A, Nuskabayeva G, Baimakhanova G, Raimova M, Alikulova N, Khamidova N, Isanova S, Azizkhojayeva D, Turmanbayeva A, Kemelbekov K.   +11 more
europepmc   +1 more source

Chemical and Biological Determinants of PEG‐Lipid Shedding From Therapeutic Nanoparticles

Small, Volume 22, Issue 58, 16 October 2026.
PEG‐lipids play a central role in governing lipid nanoparticle stability, targeting, and function. However, PEG‐lipids can “shed” from the nanoparticle surface in biological environments, with the extent and kinetics of shedding influenced by chemical and biological factors.
Ethan P. Cisneros, Aadya S. Wijesekera, Lisa R. Volpatti   +2 more
wiley   +1 more source

Transport pathways across the blood-brain barrier for waste clearance and drug delivery. [PDF]

Fluids Barriers CNS
Gröbner LS, Pietrzik CU.
europepmc   +1 more source

Aetiology‐Specific Pancreatic Enzyme Dose Requirements and Treatment Outcomes in Pancreatic Exocrine Insufficiency: The Multicentre EURO‐PEI Registry

United European Gastroenterology Journal, Volume 14, Issue 8, October 2026.
ABSTRACT Background Pancreatic exocrine insufficiency (PEI) is a maldigestion syndrome leading to symptoms and nutritional deficiencies. Prospective real‐world data on pancreatic enzyme replacement therapy (PERT) dose requirements across aetiologies are limited. Objective To define PERT dose requirements and treatment outcomes across PEI aetiologies in
J. Enrique Domínguez‐Muñoz, Yessica Domínguez‐Novoa, Xurxo Martínez‐Seara, Peter Hegyi, Vinciane Rebours, Mary E. Phillips, Federico Bolado, Gabriele Capurso, Giulia de Marchi, Keith J. Roberts, Orsolya Eperjesi, Sandra Salmeron, David Ruiz‐Clavijo, Gaetano Lauri, Alessandro Brillo, Sarah Powell‐Brett, Jose Lariño‐Noia, Julio Iglesias‐García   +17 more
wiley   +1 more source

Iron Status, Erythropoietin, and Cancer Incidence in the General Population. [PDF]

Eur J Clin Invest
van Alfen SJ, Rawee P, Luo L, Nolte IM, van der Vegt B, Kootstra-Ros JE, Bakker SJL, Gansevoort RT, Links TP, Zandee WT, Eisenga MF.   +10 more
europepmc   +1 more source